Literature DB >> 2614012

More on smoking habits and Graves' ophthalmopathy.

L Bartalena1, E Martino, C Marcocci, F Bogazzi, M Panicucci, F Velluzzi, A Loviselli, A Pinchera.   

Abstract

Since a relationship between cigarette smoking and the occurrence of Graves' ophthalmopathy has been recently postulated, we reviewed the smoking habits of 1730 women, including subjects without thyroid disease, with nontoxic goiter (NTG), toxic nodular goiter or toxic adenoma (TNG), Hashimoto's thyroiditis (HT), Graves' disease without ophthalmopathy (GD) or with ophthalmopathy (GO). The prevalence of smokers in NTG, TNG and HT was about 30%, not different from that of controls. Smokers were 47.9% in GD and 64.2% in GO groups. The latter figures were highly different from those of the other groups and also from each other. The percentage of heavy smokers was higher in patients with more severe ophthalmopathy. No clear explanation for this phenomenon can be offered. The absence of a high prevalence of smokers among patients with non-toxic goiter, nonautoimmune hyperthyroidism and Hashimoto's thyroiditis, limits the impact that smoking might have had in the pathogenesis of goiter, hyperthyroidism and autoimmune phenomena of GD and GO.

Entities:  

Mesh:

Year:  1989        PMID: 2614012     DOI: 10.1007/BF03350047

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Influence of the sympathetic nervous system on the secretion and metabolism of thyroid hormone.

Authors:  A Melander; U Westgren; L E Ericson; F Sundler
Journal:  Endocrinology       Date:  1977-10       Impact factor: 4.736

2.  Studies on the occurrence of ophthalmopathy in Graves' disease.

Authors:  C Marcocci; L Bartalena; F Bogazzi; M Panicucci; A Pinchera
Journal:  Acta Endocrinol (Copenh)       Date:  1989-04

3.  Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes.

Authors:  U Costabel; K J Bross; C Reuter; K H Rühle; H Matthys
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

4.  Is endocrine ophthalmopathy related to smoking?

Authors:  E Hägg; K Asplund
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-12

Review 5.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

6.  Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women.

Authors:  S B Christensen; U B Ericsson; L Janzon; S Tibblin; A Melander
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

7.  Influence of smoking on thyroid activity.

Authors:  A Melander; E Nordenskjöld; B Lundh; J Thorell
Journal:  Acta Med Scand       Date:  1981

8.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.

Authors:  P E Cryer; M W Haymond; J V Santiago; S D Shah
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

9.  Effect of smoking on human natural killer cell activity.

Authors:  B Phillips; M E Marshall; S Brown; J S Thompson
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

10.  Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.

Authors:  L Bartalena; C Marcocci; L Chiovato; M Laddaga; G Lepri; D Andreani; G Cavallacci; L Baschieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

View more
  31 in total

1.  Smoking and Graves' disease.

Authors:  Luigi Bartalena
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

Review 2.  Relationship between cigarette smoking and Graves' ophthalmopathy.

Authors:  L Hegediüs; T H Brix; P Vestergaard
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 3.  [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

Authors:  A Eckstein; J Esser
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

Review 4.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

5.  The impact of smoking on thyroid volume and function in relation to a shift towards iodine sufficiency.

Authors:  Pernille Vejbjerg; Nils Knudsen; Hans Perrild; Allan Carlé; Peter Laurberg; Inge Bülow Pedersen; Lone B Rasmussen; Lars Ovesen; Torben Jørgensen
Journal:  Eur J Epidemiol       Date:  2008-04-26       Impact factor: 8.082

Review 6.  Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.

Authors:  James A Garrity; Rebecca S Bahn
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

7.  Adult coeliac disease and cigarette smoking.

Authors:  J A Snook; L Dwyer; C Lee-Elliott; S Khan; D W Wheeler; D S Nicholas
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

Review 8.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

Review 9.  Graves' orbitopathy: imperfect treatments for a rare disease.

Authors:  Luigi Bartalena
Journal:  Eur Thyroid J       Date:  2013-11-20

10.  Radiotherapy in the treatment of Graves ophthalmopathy-to do it or not?

Authors:  Aneta Zygulska
Journal:  J Ocul Biol Dis Infor       Date:  2009-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.